| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $64,849,459 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P20GM134973 | Oklahoma Center for Microbial Pathogenesis and Immunity | 003 | 5 | NIH | 5/6/2024 | $214,963 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P20GM134973 | Oklahoma Center for Microbial Pathogenesis and Immunity | 001 | 5 | NIH | 1/25/2024 | $1,934,669 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK131064 | Sulfur Amino Acid Metabolism and Regulation of Hepatic Metabolic Flexibility | 001 | 3 | NIH | 5/9/2024 | $24,726 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK131064 | Sulfur Amino Acid Metabolism and Regulation of Hepatic Metabolic Flexibility | 000 | 3 | NIH | 12/5/2023 | $370,911 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21CA271218 | Non-invasive assessment of graft vs host disease using optoacoustic imaging | 001 | 2 | NIH | 4/17/2024 | $10,169 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21CA271218 | Non-invasive assessment of graft vs host disease using optoacoustic imaging | 000 | 2 | NIH | 12/21/2023 | $183,026 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9952111 | Value-Based Medical Student Education Training Program | 00 | 2 | HRSA | 6/17/2024 | $3,999,999 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | NU58DP007727 | Building Capacity for and Promoting Awareness of Evidence-based Prevention and Management of Chronic Venous Thromboembolism | 00 | 2 | CDC | 6/20/2024 | $374,000 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31DE033289 | Understanding the role of PDGFRb signaling in Penttinen syndrome craniofacial development | 000 | 1 | NIH | 1/12/2024 | $35,738 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R03CA289562 | Role of JMJD4 in Breast Cancer | 000 | 1 | NIH | 2/23/2024 | $72,500 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL169530 | Mechanism of F-18-fluorodeoxyglucarate accrual in myocardial injury | 000 | 1 | NIH | 3/29/2024 | $362,500 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F30AG087705 | Regulation of Microglial Function by Major Histocompatibility Complex I in Aging and Alzheimer's Disease | 001 | 1 | NIH | 6/7/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F30AG087705 | Regulation of Microglial Function by Major Histocompatibility Complex I in Aging and Alzheimer's Disease | 000 | 1 | NIH | 6/7/2024 | $44,477 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R33AG072137 | A New Translational Rat Model for Evaluating Anti-Aging Interventions | 000 | 3 | NIH | 6/21/2024 | $728,662 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK139443 | Evaluating PQQ for preventing maternal obesity-induced fetal programming of juvenile NAFLD in Papio anubis | 000 | 1 | NIH | 3/14/2024 | $621,994 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG1CA287044 | Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub | 000 | 1 | NIH | 2/14/2024 | $805,511 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI185203 | Targeting chondroitin sulfate proteoglycan 4 (CSPG4) expression as a Clostridioides difficile therapeutic | 000 | 1 | NIH | 5/15/2024 | $321,750 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG072295 | Cerebromicrovascular rejuvenation by heterochronic blood exchange | 000 | 2 | NIH | 5/21/2024 | $442,112 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG3CA290310 | Discovery and Development of Natural Products for Interception of CRC | 000 | 1 | NIH | 5/14/2024 | $303,875 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21EY035725 | Targeting Innate Inflammation Pathways to Treat Ocular Infections | 000 | 1 | NIH | 12/15/2023 | $181,250 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK133207 | ROCK, tight junctions and prematurity in the pathogenesis of necrotizing enterocolitis and neonatal sepsis. | 001 | 2 | NIH | 5/20/2024 | $28,976 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK133207 | ROCK, tight junctions and prematurity in the pathogenesis of necrotizing enterocolitis and neonatal sepsis. | 000 | 2 | NIH | 1/19/2024 | $434,659 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY034742 | Metabolic reprogramming of endothelial precursor cells in subretinal fibrosis | 000 | 2 | NIH | 6/21/2024 | $448,144 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R35GM151013 | Understanding the molecular mechanisms of cilia formation | 000 | 2 | NIH | 7/16/2024 | $362,500 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21MD019385 | Chronic health conditions and uptake of COVID-19 testing and vaccination among Native Americans in the RADx-UP Consortium | 000 | 2 | NIH | 6/20/2024 | $175,285 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21AG080775 | Time restricted eating for prevention of age-related vascular cognitive decline in older adults | 001 | 2 | NIH | 7/10/2024 | $181,250 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U19AI174994 | Advancing a second generation C. difficile vaccine | 000 | 2 | NIH | 7/8/2024 | $1,315,168 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY035282 | Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease | 000 | 2 | NIH | 7/3/2024 | $429,322 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI168175 | DNA sequence selectivity in conventional and aberrant V(D)J recombination | 000 | 2 | NIH | 7/17/2024 | $350,000 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI168175 | DNA sequence selectivity in conventional and aberrant V(D)J recombination | 000 | 2 | NIH | 7/17/2024 | $101,311 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI173108 | Understanding and leveraging immunometabolism to combat Clostridioides difficile infection | 000 | 2 | NIH | 7/5/2024 | $530,991 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U54HD113173 | Building Data Capacity for Maternal Health Equity | 002 | 2 | NIH | 7/11/2024 | $200,680 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U54HD113173 | Building Data Capacity for Maternal Health Equity | 001 | 2 | NIH | 7/10/2024 | $1,453,504 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HD110585 | Preconception Maternal Nutrition, Offspring DNA Methylation, and InfantGrowth in Low Resource Settings | 001 | 2 | NIH | 5/8/2024 | $498,046 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HD109784 | Prevention of Necrotizing Enterocolitis | 001 | 2 | NIH | 5/6/2024 | $36,840 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HD109784 | Prevention of Necrotizing Enterocolitis | 000 | 2 | NIH | 2/7/2024 | $368,415 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21AI175595 | Functional and transcriptome analyses of protein kinases in Candida glabrata antifungal drug resistance | 002 | 2 | NIH | 5/20/2024 | $21,750 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21AI175595 | Functional and transcriptome analyses of protein kinases in Candida glabrata antifungal drug resistance | 001 | 2 | NIH | 2/14/2024 | $195,750 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21CA280437 | Pro-Oncogenic Role of a Mitochondrial Lipid Kinase in CLL | 001 | 2 | NIH | 4/17/2024 | $10,169 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21CA280437 | Pro-Oncogenic Role of a Mitochondrial Lipid Kinase in CLL | 000 | 2 | NIH | 2/21/2024 | $183,026 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T8R53147 | Primary Care Training and Enhancement: Physician Assistant Rural Training in Mental and Behav. Hlth | 01 | 1 | HRSA | 7/19/2024 | $41,667 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy # URP865-450 | Oklahoma City | OK | 73104-3607 | OKLAHOMA | USA | T8R53147 | Primary Care Training and Enhancement: Physician Assistant Rural Training in Mental and Behav. Hlth | 00 | 1 | HRSA | 6/3/2024 | $415,000 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21CA280049 | Investigating the impact of local land use and zoning policies on equitably reducing tobacco retailer availability | 000 | 2 | NIH | 4/9/2024 | $204,412 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R25GM144169 | Post-Baccalaureate Research and Education Program (PREP) for Oklahoma | 002 | 2 | NIH | 6/18/2024 | $26,977 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R25GM144169 | Post-Baccalaureate Research and Education Program (PREP) for Oklahoma | 001 | 2 | NIH | 2/22/2024 | $242,790 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U01DK135007 | Identifying Metabolic and Psychosocial Antecedents and Characteristics of youth-onset Type 2 diabetes (IMPACT DM) | 001 | 2 | NIH | 6/18/2024 | $61,422 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U01DK135007 | Identifying Metabolic and Psychosocial Antecedents and Characteristics of youth-onset Type 2 diabetes (IMPACT DM) | 002 | 2 | NIH | 7/16/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U01DK135007 | Identifying Metabolic and Psychosocial Antecedents and Characteristics of youth-onset Type 2 diabetes (IMPACT DM) | 000 | 2 | NIH | 3/5/2024 | $552,800 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA059480 | Elucidating minority stress influences on tobacco use at the intersection of sexual orientation and rurality | 000 | 1 | NIH | 7/22/2024 | $406,246 |
|